Crossmark

Possible role of plasma Galectin-9 levels as a surrogate marker of viremia in HIV infected patients on antiretroviral therapy in resource-limited settings

Crossref DOI link: https://doi.org/10.1186/s12981-020-00298-9

Published Online: 2020-07-16

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shete, Ashwini http://orcid.org/0000-0003-0791-2128
Dhayarkar, Sampada

Dhamanage, Ashwini

Kulkarni, Smita

Ghate, Manisha

Sangle, Shashikala

Medhe, Uttam

Verma, Vinita

Rajan, Shobini

Hattori, Toshio

Gangakhedkar, Raman
Funding

Funding for this research was provided by:

National AIDS Control Organisation (T-11020/39/2013-NACO (R&D))
License Information

Text and Data Mining valid from 2020-07-16

Version of Record valid from 2020-07-16
More Information

Article History

Received: 31 December 2019

Accepted: 7 July 2020

First Online: 16 July 2020

Ethics approval and consent to participate

: The study was approved by Ethics committees of ICMR-National AIDS Research Institute and National AIDS Control Organization (Protocol Number: NARI-EC/2014-07). Written informed consent was obtained from all the participants before enrolling them in the study.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below